371 related articles for article (PubMed ID: 32144625)
1. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
Pan L; Du J; Liu J; Liao H; Liu X; Guo X; Liang J; Han H; Yang L; Zhou Y
Clin Rheumatol; 2020 Aug; 39(8):2369-2378. PubMed ID: 32144625
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of tocilizumab for the treatment of Chinese Takayasu's arteritis.
Zhou J; Chen Z; Li J; Yang Y; Zhao J; Chen H; Liu M; Sun F; Li M; Tian X; Zeng X
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):171-175. PubMed ID: 28406764
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of tocilizumab in patients with Takayasu arteritis].
Liao H; Pan LL; Du J; Gao N; Wang T
Zhonghua Nei Ke Za Zhi; 2019 Jun; 58(6):444-448. PubMed ID: 31159524
[No Abstract] [Full Text] [Related]
4. Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review.
Li H; Shuai Z
Heart Vessels; 2022 May; 37(5):884-894. PubMed ID: 34750666
[TBL] [Abstract][Full Text] [Related]
5. Development of severe colitis in Takayasu arteritis treated with tocilizumab.
Ishii K; Shirai T; Kakuta Y; Machiyama T; Sato H; Ishii T; Harigae H; Fujii H
Clin Rheumatol; 2022 Jun; 41(6):1911-1918. PubMed ID: 35188603
[TBL] [Abstract][Full Text] [Related]
6. Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center.
Tombetti E; Franchini S; Papa M; Sabbadini MG; Baldissera E
J Rheumatol; 2013 Dec; 40(12):2047-51. PubMed ID: 24187104
[TBL] [Abstract][Full Text] [Related]
7. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
[TBL] [Abstract][Full Text] [Related]
8. Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis: an open-label study.
Wang J; Kong X; Ma L; Ding Z; Chen H; Chen R; Jin X; Chen C; Lin J; Jiang L
Rheumatology (Oxford); 2024 May; 63(5):1359-1367. PubMed ID: 37540159
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy.
Yoshifuji H
Mod Rheumatol; 2019 Mar; 29(2):287-293. PubMed ID: 30427262
[TBL] [Abstract][Full Text] [Related]
10. Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study.
Saito S; Okuyama A; Okada Y; Shibata A; Sakai R; Kurasawa T; Kondo T; Takei H; Amano K
Rheumatology (Oxford); 2020 Jul; 59(7):1617-1621. PubMed ID: 31665468
[TBL] [Abstract][Full Text] [Related]
11. Intravenous tocilizumab for Takayasu arteritis with aortic aneurysms, bilateral renal artery stenosis, and atypical aortic coarctation in a 2-year-old girl.
Fujita Y; Tomiita M; Saida S; Omura S; Sato M; Otsubo Y; Takagi Y; Kano Y; Sekine K; Fukushima K; Kuwashima S; Yoshihara S
Mod Rheumatol Case Rep; 2023 Jan; 7(1):160-165. PubMed ID: 36018053
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of tocilizumab for intractable Takayasu arteritis and
Isobe M; Maejima Y; Saji M; Tateishi U
J Cardiol; 2021 May; 77(5):539-544. PubMed ID: 33451862
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials.
Singh A; Danda D; Hussain S; Najmi AK; Mathew A; Goel R; Lakhan SE; Tajudheen B; Antony B
Mod Rheumatol; 2021 Jan; 31(1):197-204. PubMed ID: 32000551
[TBL] [Abstract][Full Text] [Related]
14. Tocilizumab and refractory Takayasu disease: Four case reports and systematic review.
Decker P; Olivier P; Risse J; Zuily S; Wahl D
Autoimmun Rev; 2018 Apr; 17(4):353-360. PubMed ID: 29427826
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis.
Kang L; Liu Y; Luo Z; Zhou Y; Chen B; Yin G; Xie Q
Front Immunol; 2023; 14():1084558. PubMed ID: 36845158
[TBL] [Abstract][Full Text] [Related]
17. Tocilizumab: a novel therapy for patients with large-vessel vasculitis.
Salvarani C; Magnani L; Catanoso M; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
Rheumatology (Oxford); 2012 Jan; 51(1):151-6. PubMed ID: 22075063
[TBL] [Abstract][Full Text] [Related]
18. Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review.
Loricera J; Blanco R; Hernández JL; Castañeda S; Humbría A; Ortego N; Bravo B; Freire M; Melchor S; Mínguez M; Salvatierra J; González-Vela C; Calvo-Río V; Santos-Gómez M; Pina T; González-Gay MA
Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S44-53. PubMed ID: 27050507
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients.
Mekinian A; Resche-Rigon M; Comarmond C; Soriano A; Constans J; Alric L; Jego P; Busato F; Cabon M; Dhote R; Estibaliz L; Koné-Paut I; Landron C; Lavigne C; Lioger B; Michaud M; Ruivard M; Sacre K; Gottenberg JE; Gaches F; Goulenok T; Salvarani C; Cacoub P; Fain O; Saadoun D;
J Autoimmun; 2018 Jul; 91():55-60. PubMed ID: 29678346
[TBL] [Abstract][Full Text] [Related]
20. Tocilizumab for faster and safer remission of Takayasu's arteritis.
Liao H; Du J; Li T; Pan L
Ther Adv Chronic Dis; 2022; 13():20406223221131715. PubMed ID: 36324988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
